Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Akoya Biosciences Inc

Current price
2.3 USD +0.25 USD (+12.20%)
Last closed 1.97 USD
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 97 043 888 USD
Yield for 12 month -60.07 %
21.11.2021 - 28.11.2021

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Address: 100 Campus Drive, Marlborough, MA, United States, 01752

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

6.67 USD

P/E ratio

Dividend Yield

Current Year

+96 633 000 USD

Last Year

+74 859 000 USD

Current Quarter

+18 350 000 USD

Last Quarter

+26 487 000 USD

Current Year

+48 238 000 USD

Last Year

+43 390 000 USD

Current Quarter

+8 379 000 USD

Last Quarter

+14 746 000 USD

Key Figures AKYA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -47 041 000 USD
Operating Margin TTM -92.85 %
PE Ratio
Return On Assets TTM -22.59 %
PEG Ratio
Return On Equity TTM -181.72 %
Wall Street Target Price 6.67 USD
Revenue TTM 93 573 000 USD
Book Value 0.66 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -14.3 %
Dividend Yield
Gross Profit TTM 43 390 000 USD
Earnings per share -1.42 USD
Diluted Eps TTM -1.42 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -72.68 %

Dividend Analytics AKYA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AKYA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AKYA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.136
Price Sales TTM 2.1002
Enterprise Value EBITDA -4.5234
Price Book MRQ 3.7908

Financials AKYA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AKYA

For 52 weeks

1.88 USD 8.8 USD
50 Day MA 3.97 USD
Shares Short Prior Month 1 036 326
200 Day MA 4.53 USD
Short Ratio 4.65
Shares Short 1 159 003
Short Percent 3.88 %

Dynamics of changes in the value of assets




430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds



14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics